{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:39:24Z","timestamp":1792175964446,"version":"4.4.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.micpath.2024.107275","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:34:45Z","timestamp":1736426085000},"page":"107275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Emerging threats: Antimicrobial resistance in extended-spectrum beta-lactamase and carbapenem-resistant Escherichia coli"],"prefix":"10.1016","volume":"200","author":[{"given":"Mamdouh S.","family":"Aljohni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-4620","authenticated-orcid":false,"given":"Mohammad","family":"Harun-Ur-Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4025-8586","authenticated-orcid":false,"given":"Samy","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2024.107275_bib1","article-title":"Antimicrobial resistance: impacts, challenges, and future prospects","volume":"2","author":"Ahmed","year":"2024","journal-title":"J. Med. Sur. Publ.Health."},{"issue":"2","key":"10.1016\/j.micpath.2024.107275_bib2","first-page":"51","article-title":"Claudia, the post-antibiotic era: an existential threat for humanity","volume":"8","author":"Koesling","year":"2022","journal-title":"Intergener. Justice Rev."},{"key":"10.1016\/j.micpath.2024.107275_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11081082","article-title":"Antimicrobial resistance and its spread is a global threat","volume":"11","author":"Aljeldah","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2024.107275_bib4","series-title":"Diagnostic Stewardship: a Guide to Implementation in Antimicrobial Resistance Surveillance Sites","author":"World Health","year":"2016"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ajlm.v11i1.1594","article-title":"Global antimicrobial resistance and use surveillance system on the African continent: early implementation 2017-2019","volume":"11","author":"Tornimbene","year":"2022","journal-title":"Afr. J. Lab. Med."},{"key":"10.1016\/j.micpath.2024.107275_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mjafi.2024.07.006","article-title":"Antimicrobial resistance: current challenges and future directions","author":"Puri","year":"2024","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.micpath.2024.107275_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fsci.2024.1298248","article-title":"Real-time genomic surveillance for enhanced control of infectious diseases and antimicrobial resistance","volume":"2","author":"Struelens","year":"2024","journal-title":"Front. Sci."},{"issue":"10443","key":"10.1016\/j.micpath.2024.107275_bib8","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0140-6736(24)00878-X","article-title":"Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance","volume":"403","author":"Laxminarayan","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2024.107275_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17093061","article-title":"Factors obscuring the role of E. coli from domestic animals in the global antimicrobial resistance crisis: an evidence-based review","volume":"17","author":"Loayza","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.micpath.2024.107275_bib10","series-title":"Antibiotic Drug Resistance","first-page":"239","article-title":"Antibiotic resistance","author":"Carvalho","year":"2019"},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ajic.2020.07.035","article-title":"Risk factors for fecal carriage of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains among patients at hospital admission","volume":"49","author":"Kizilates","year":"2021","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.micpath.2024.107275_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ani14172490","article-title":"The global rise of ESBL-producing Escherichia coli in the livestock sector: a five-year overview","volume":"14","author":"Mandujano-Hern\u00e1ndez","year":"2024","journal-title":"Animals"},{"key":"10.1016\/j.micpath.2024.107275_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11112937","article-title":"Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities","volume":"11","author":"Husna","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2024.107275_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2022.101815","article-title":"Global epidemiology of CTX-M-type \u03b2-lactam resistance in human and animal","volume":"86","author":"Rana","year":"2022","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107275_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jgar.2023.11.013","article-title":"Epidemiology and molecular characterization of CTX-M-type ESBLs producing Escherichia coli isolated from clinical settings","volume":"36","author":"Yu","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.micpath.2024.107275_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00110","article-title":"CTX-M enzymes: origin and diffusion","volume":"3","author":"Canton","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.107275_bib17","series-title":"Antibiotic Discovery and Development","first-page":"427","article-title":"Evolution of \u03b2-lactamases: past, present, and future","author":"Bush","year":"2012"},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib18","doi-asserted-by":"crossref","first-page":"dlab092","DOI":"10.1093\/jacamr\/dlab092","article-title":"Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection","volume":"3","author":"Castanheira","year":"2021","journal-title":"JAC-Antimicrob. Resist."},{"issue":"10","key":"10.1016\/j.micpath.2024.107275_bib19","article-title":"Diversity, functional classification and genotyping of SHV \u03b2-lactamases in Klebsiella pneumoniae","volume":"10","author":"Tsang","year":"2024","journal-title":"Microb. Genom."},{"key":"10.1016\/j.micpath.2024.107275_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01374","article-title":"A review of SHV extended-spectrum \u03b2-lactamases: neglected yet ubiquitous","volume":"7","author":"Liakopoulos","year":"2016","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2024.107275_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/1060028017748943","article-title":"Is it time to rethink the notion of carbapenem-sparing therapy against extended-spectrum \u03b2-lactamase\u2013producing Enterobacteriaceae bloodstream infections? A critical review","volume":"52","author":"Chastain","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.micpath.2024.107275_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11020277","article-title":"The Role of Colistin in the Era of new \u03b2-Lactam\/\u03b2-Lactamase inhibitor combinations","volume":"11","author":"Aslan","year":"2022","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.micpath.2024.107275_bib23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","article-title":"Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study","volume":"71","author":"Esteve-Palau","year":"2015","journal-title":"J. Infect."},{"key":"10.1016\/j.micpath.2024.107275_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7090363","article-title":"Horizontal gene transfer and its association with antibiotic resistance in the genus aeromonas spp","volume":"7","author":"Bello-L\u00f3pez","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2024.107275_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105040","article-title":"Genetic basis of molecular mechanisms in \u03b2-lactam resistant gram-negative bacteria","volume":"158","author":"Hussain","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2024.107275_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1387497","article-title":"A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli","volume":"14","author":"Nasrollahian","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41579-021-00650-4","article-title":"Horizontal gene transfer and adaptive evolution in bacteria","volume":"20","author":"Arnold","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2024.107275_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1444781","article-title":"Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review","volume":"15","author":"Belay","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107275_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.952491","article-title":"Deciphering the genetic network and programmed regulation of antimicrobial resistance in bacterial pathogens","volume":"12","author":"Ramamurthy","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2024.107275_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmsacl.2022.09.001","article-title":"Molecular phenotyping approaches for the detection and monitoring of carbapenem-resistant Enterobacteriaceae by mass spectrometry","volume":"26","author":"Dixon","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.micpath.2024.107275_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00895","article-title":"Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods","volume":"7","author":"Lee","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.107275_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13144199","article-title":"New Delhi metallo-beta-lactamase inhibitors: a systematic scoping review","volume":"13","author":"Nahar","year":"2024","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.micpath.2024.107275_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/S1676-24442013000600003","article-title":"Oxacillinase (OXA)-producing Acinetobacter baumannii in Brazil: clinical and environmental impact and therapeutic options","volume":"49","author":"Medeiros","year":"2013","journal-title":"J. Bras. Patol. Med. Lab."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12866-024-03283-8","article-title":"Characterization of genes related to the efflux pump and porin in multidrug-resistant Escherichia coli strains isolated from patients with COVID-19 after secondary infection","volume":"24","author":"Ganjo","year":"2024","journal-title":"BMC Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2024.107275_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01172-17","article-title":"Synergy between active efflux and outer membrane diffusion defines rules of antibiotic permeation into gram-negative bacteria","volume":"8","author":"Krishnamoorthy","year":"2017","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01413-16","article-title":"Acquisition of carbapenem resistance by plasmid-encoded-AmpC-expressing Escherichia coli","volume":"61","author":"van Boxtel","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107275_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodcont.2022.108937","article-title":"Plasmid-mediated ciprofloxacin, carbapenem and colistin resistance of a foodborne Escherichia coli isolate","volume":"137","author":"Liu","year":"2022","journal-title":"Food Control"},{"issue":"6","key":"10.1016\/j.micpath.2024.107275_bib38","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1111\/jam.15130","article-title":"Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital\u2010acquired infections: a scientific review","volume":"131","author":"Nguyen","year":"2021","journal-title":"J. Appl. Microbiol."},{"issue":"19","key":"10.1016\/j.micpath.2024.107275_bib39","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1016\/j.cub.2020.07.019","article-title":"Antibiotics interfere with the evolution of plasmid stability","volume":"30","author":"Wein","year":"2020","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib40","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-056219","article-title":"Urinary tract infections treated by third-generation cephalosporins","volume":"150","author":"Bradley","year":"2022","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.diagmicrobio.2019.01.020","article-title":"Antimicrobial treatment challenges in the era of carbapenem resistance","volume":"94","author":"Peri","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.107275_bib42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.micpath.2017.11.061","article-title":"The prevalence and drug resistance pattern of extended spectrum \u03b2\u2013lactamases (ESBLs) producing Enterobacteriaceae in Africa","volume":"114","author":"Saravanan","year":"2018","journal-title":"Microb. Pathog."},{"issue":"14","key":"10.1016\/j.micpath.2024.107275_bib43","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s40265-019-01180-3","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options","volume":"79","author":"Peirano","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.micpath.2024.107275_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/medicina60091528","article-title":"Predominance of blaNDM- and blaIMP-harboring Escherichia coli belonging to clonal complexes 131 and 23 in a major university hospital","volume":"60","author":"Shafiq","year":"2024","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13756-022-01055-5","article-title":"Blood bacterial resistant investigation collaborative system (BRICS) report: a national surveillance in China from 2014 to 2019","volume":"11","author":"Chen","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib46","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jac\/dkaa514","article-title":"Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study","volume":"76","author":"Larramendy","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2024.107275_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11908-018-0634-9","article-title":"Travel and the spread of drug-resistant bacteria","volume":"20","author":"Schwartz","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.micpath.2024.107275_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijfoodmicro.2017.01.011","article-title":"Spread of ESBL\/AmpC-producing Escherichia coli and Klebsiella pneumoniae in the community through ready-to-eat sandwiches in Algeria","volume":"245","author":"Yaici","year":"2017","journal-title":"Int. J. Food Microbiol."},{"issue":"6","key":"10.1016\/j.micpath.2024.107275_bib49","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4269\/ajtmh.18-0726","article-title":"Antibiotic resistance in Enterobacteriaceae from surface waters in urban Brazil highlights the risks of poor sanitation","volume":"100","author":"Bartley","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14252\/foodsafetyfscj.2017011","article-title":"ESBL-producing Escherichia coli and its rapid rise among healthy people","volume":"5","author":"Kawamura","year":"2017","journal-title":"Food. Saf."},{"key":"10.1016\/j.micpath.2024.107275_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11030421","article-title":"Mechanisms of action of carbapenem resistance","volume":"11","author":"Aurilio","year":"2022","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.micpath.2024.107275_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251594","article-title":"\u03b2-lactam resistance associated with \u03b2-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae","volume":"16","author":"Khalifa","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2352432","article-title":"Porin deficiency or plasmid copy number increase mediated carbapenem-resistant Escherichia coli resistance evolution","volume":"13","author":"Xiang","year":"2024","journal-title":"Emerg. Microb. Infect."},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105919","article-title":"Contribution of \u03b2-lactamase and efflux pump overproduction to tazobactam-piperacillin resistance in clinical isolates of Escherichia coli","volume":"55","author":"Suzuki","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/apm.13015","article-title":"Quercetin inhibits carbapenemase and efflux pump activities among carbapenem-resistant Gram-negative bacteria","volume":"128","author":"Pal","year":"2020","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib56","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jac\/dkaa534","article-title":"Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in The Netherlands (2014\u201317)","volume":"76","author":"Verschuuren","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib57","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12866-021-02307-x","article-title":"Genetic characterization of carbapenem-resistant Escherichia coli from China, 2015\u20132017","volume":"21","author":"Li","year":"2021","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2024.107275_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ani10122239","article-title":"Escherichia coli as commensal and pathogenic bacteria among food-producing animals: health implications of extended spectrum \u03b2-lactamase (ESBL) production","volume":"10","author":"Ramos","year":"2020","journal-title":"Animals"},{"key":"10.1016\/j.micpath.2024.107275_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01422","article-title":"Interplay between membrane permeability and enzymatic barrier leads to antibiotic-dependent resistance in Klebsiella pneumoniae","volume":"9","author":"Nicolas-Chanoine","year":"2018","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2024.107275_bib60","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11274-022-03334-0","article-title":"Occurrence of antibiotics and bacterial resistance genes in wastewater: resistance mechanisms and antimicrobial resistance control approaches","volume":"38","author":"Mutuku","year":"2022","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2024.107275_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.110767","article-title":"Hospital wastewaters: a reservoir and source of clinically relevant bacteria and antibiotic resistant genes dissemination in urban river under tropical conditions","volume":"200","author":"Al Salah","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.micpath.2024.107275_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.115260","article-title":"Dissemination of antibiotic resistance genes (ARGs) via integrons in Escherichia coli: a risk to human health","volume":"266","author":"Zhang","year":"2020","journal-title":"Environ. Pollut."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/lam.13301","article-title":"The prevalence and antimicrobial resistance phenotypes of Salmonella, Escherichia coli and Enterococcus sp. in surface water","volume":"71","author":"Cho","year":"2020","journal-title":"Lett. Appl. Microbiol."},{"issue":"6","key":"10.1016\/j.micpath.2024.107275_bib64","article-title":"ESBL activity, MDR, and carbapenem resistance among predominant enterobacterales isolated in 2019","volume":"10","author":"Bandy","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2024.107275_bib65","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2147\/IDR.S232010","article-title":"Molecular mechanisms and epidemiology of carbapenem-resistant Escherichia coli isolated from Chinese patients during 2002-2017","volume":"13","author":"Tian","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2024.107275_bib66","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2147\/IDR.S208231","article-title":"Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015","volume":"12","author":"Chang","year":"2019","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4103\/jdmimsu.jdmimsu_76_22","article-title":"Prevalence of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in rural Uttar Pradesh","volume":"17","author":"Srivastava","year":"2022","journal-title":"J. Datta. Meghe. Inst. Med. Sci. Univ."},{"key":"10.1016\/j.micpath.2024.107275_bib68","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3389\/fmicb.2018.02704","article-title":"High prevalence of bla (NDM) variants among carbapenem-resistant Escherichia coli in northern jiangsu province, China","volume":"9","author":"Bi","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.micpath.2024.107275_bib69","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2166\/wh.2020.014","article-title":"Prevalence of ESBL-producing Escherichia coli and carbapenem-resistant Enterobacteriaceae in treated wastewater: a comparison with nosocomial infection surveillance","volume":"18","author":"Urase","year":"2020","journal-title":"J. Water Health"},{"issue":"7","key":"10.1016\/j.micpath.2024.107275_bib70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2217\/fmb-2020-0193","article-title":"Epidemiology of extended-spectrum \u03b2-lactamase and metallo-\u03b2-lactamase-producing Escherichia coli in South Asia","volume":"16","author":"Islam","year":"2021","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jac\/dkw398","volume":"72","author":"Jean","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijantimicag.2019.07.019","article-title":"Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: review and mapping of emerging and overlapping challenges","volume":"54","author":"Malchione","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib73","first-page":"109","article-title":"Low Prevalence of carbapenem Resistance in clinical Isolates of extended spectrum beta lactamase (ESBL) producing Escherichia coli in North central, Nigeria","volume":"8","author":"Onyedibe","year":"2018","journal-title":"Adv. Infect. Dis."},{"issue":"16","key":"10.1016\/j.micpath.2024.107275_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18168264","article-title":"Occurrence of extended spectrum beta lactamase (ESBL) producers, quinolone and carbapenem resistant Enterobacteriaceae isolated from environmental samples along msimbazi river basin ecosystem in Tanzania","volume":"18","author":"Kimera","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106203","article-title":"Epidemiology and prevalence of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae in humans, animals and the environment in West and Central Africa","volume":"57","author":"Ouchar Mahamat","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2024.107275_bib76","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jgar.2019.09.007","article-title":"High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum beta-lactamase-producers in Nigerian hospitals","volume":"21","author":"Olalekan","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1186\/s13104-018-3738-2","article-title":"A systematic review: the current status of carbapenem resistance in East Africa","volume":"11","author":"Ssekatawa","year":"2018","journal-title":"BMC Res. Notes"},{"issue":"11","key":"10.1016\/j.micpath.2024.107275_bib78","article-title":"Extended spectrum beta-lactamase-resistant determinants among carbapenem-resistant Enterobacteriaceae from beef cattle in the North west province, South Africa: a critical assessment of their possible public health implications","volume":"9","author":"Tshitshi","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13756-023-01220-4","article-title":"Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa","volume":"12","author":"Venne","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib80","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijantimicag.2018.05.019","article-title":"Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: using diverse data to inform surveillance gaps","volume":"52","author":"Mitgang","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106535","article-title":"Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019","volume":"59","author":"Karlowsky","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"10.1016\/j.micpath.2024.107275_bib82","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/jac\/dkad127","article-title":"Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019","volume":"78","author":"Gales","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14787210.2017.1268918","article-title":"The epidemiology of carbapenemases in Latin America and the Caribbean","volume":"15","author":"Escandon-Vargas","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"2","key":"10.1016\/j.micpath.2024.107275_bib84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14787210.2020.1813023","article-title":"Update on the epidemiology of carbapenemases in Latin America and the Caribbean","volume":"19","author":"Garcia-Betancur","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1179\/1120009X12Z.0000000003","article-title":"Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009)","volume":"24","author":"Hawser","year":"2012","journal-title":"J. Chemother."},{"key":"10.1016\/j.micpath.2024.107275_bib86","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.2147\/IDR.S371845","article-title":"Extended-spectrum beta-lactamases producing Escherichia coli in South America: a systematic review with a one health perspective","volume":"15","author":"Bastidas-Caldes","year":"2022","journal-title":"Infect. Drug Resist."},{"issue":"2","key":"10.1016\/j.micpath.2024.107275_bib87","doi-asserted-by":"crossref","first-page":"ofad038","DOI":"10.1093\/ofid\/ofad038","article-title":"Trends of beta-lactamase occurrence among Escherichia coli and Klebsiella pneumoniae in United States hospitals during a 5-year period and activity of antimicrobial agents against isolates stratified by beta-lactamase type","volume":"10","author":"Castanheira","year":"2023","journal-title":"Open Forum Infect. Dis."},{"issue":"7","key":"10.1016\/j.micpath.2024.107275_bib88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/fpd.2020.2898","article-title":"Detection of extended-spectrum beta-lactamase-producing and carbapenem-resistant bacteria from mink feces and feed in the United States","volume":"18","author":"Agga","year":"2021","journal-title":"Foodb. Pathog. Dis."},{"issue":"12","key":"10.1016\/j.micpath.2024.107275_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220265","article-title":"The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017","volume":"14","author":"Critchley","year":"2019","journal-title":"PLoS One"},{"issue":"Suppl 4","key":"10.1016\/j.micpath.2024.107275_bib90","doi-asserted-by":"crossref","first-page":"iv64","DOI":"10.1093\/jac\/dkz289","article-title":"Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016","volume":"74","author":"Denisuik","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"suppl_1","key":"10.1016\/j.micpath.2024.107275_bib91","doi-asserted-by":"crossref","first-page":"i57","DOI":"10.1093\/jac\/dkt027","article-title":"Molecular epidemiology of extended-spectrum \u03b2-lactamase-, AmpC \u03b2-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007\u201311","volume":"68","author":"Denisuik","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.micpath.2024.107275_bib92","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1093\/jac\/dkab269","article-title":"ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18","volume":"76","author":"Karlowsky","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.micpath.2024.107275_bib93","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jac\/dks046","article-title":"Carbapenem-resistant gram-negative bacilli in Canada 2009\u201310: results from the Canadian nosocomial infection surveillance program (CNISP)","volume":"67","author":"Mataseje","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib94","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkaa399","article-title":"The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community","volume":"76","author":"Bezabih","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2024.107275_bib95","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10096-018-3292-9","article-title":"Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015)","volume":"37","author":"De Angelis","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"8","key":"10.1016\/j.micpath.2024.107275_bib96","article-title":"ESBL-producing, carbapenem- and ciprofloxacin-resistant Escherichia coli in Belgian and Dutch broiler and pig farms: a cross-sectional and cross-border study","volume":"10","author":"De Koster","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2024.107275_bib97","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijfoodmicro.2016.10.036","article-title":"Evaluation of meat, fruit and vegetables from retail stores in five United Kingdom regions as sources of extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant Escherichia coli","volume":"241","author":"Randall","year":"2017","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.micpath.2024.107275_bib98","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3389\/fmicb.2019.02465","article-title":"Phenotypic and molecular epidemiology of ESBL-, AmpC-, and carbapenemase-producing Escherichia coli in northern and eastern Europe","volume":"10","author":"Sepp","year":"2019","journal-title":"Front. Microbiol."},{"issue":"46","key":"10.1016\/j.micpath.2024.107275_bib99","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.46.2001815","article-title":"Emergence of carbapenem-resistant ST131 Escherichia coli carrying bla(OXA-244) in Germany, 2019 to 2020","volume":"25","author":"Welker","year":"2020","journal-title":"Euro Surveill."},{"issue":"2","key":"10.1016\/j.micpath.2024.107275_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297921","article-title":"Global antimicrobial resistance and use surveillance system (GLASS 2022): investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries","volume":"19","author":"Ajulo","year":"2024","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.micpath.2024.107275_bib101","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1517\/14656566.2016.1154538","article-title":"Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria","volume":"17","author":"D'Angelo","year":"2016","journal-title":"Expet Opin. Pharmacother."},{"issue":"Supplement_7","key":"10.1016\/j.micpath.2024.107275_bib102","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant gram-negative bacterial infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2024.107275_bib103","doi-asserted-by":"crossref","first-page":"ofy336","DOI":"10.1093\/ofid\/ofy336","article-title":"Appropriate treatment for bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae and Escherichia coli: a nationwide multicenter study in taiwan","volume":"6","author":"Lin","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"9","key":"10.1016\/j.micpath.2024.107275_bib104","article-title":"Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: an evolutionary overview","volume":"66","author":"Hobson Claire","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.micpath.2024.107275_bib105","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/14656566.2018.1512586","article-title":"Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis","volume":"19","author":"Wu","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.micpath.2024.107275_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113747","article-title":"Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1)","volume":"225","author":"Nagulapalli Venkata","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.micpath.2024.107275_bib107","first-page":"e00216","article-title":"OXA-48-Like \u03b2-lactamases: global epidemiology, treatment options, and development pipeline","volume":"66","author":"Boyd Sara","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107275_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/app10217654","article-title":"Phage therapy: consider the past, embrace the future","volume":"10","author":"Wei","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.micpath.2024.107275_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/v15091843","article-title":"Antibiotic-resistant ESKAPE pathogens and COVID-19: the pandemic beyond the pandemic","volume":"15","author":"Catalano","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.micpath.2024.107275_bib110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpam.2021.03.001","article-title":"Diagnosis and management of community-acquired urinary tract infection in infants and children: clinical guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS)","volume":"8","author":"Albarrak","year":"2021","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.micpath.2024.107275_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.823684","article-title":"Global threat of carbapenem-resistant gram-negative bacteria","volume":"12","author":"Jean","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2024.107275_bib112","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jiac.2024.05.001","article-title":"Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by third-generation cephalosporin-resistant gram-negative bacteria: a systematic review and meta-analysis of randomised controlled trials","volume":"30","author":"Maeda","year":"2024","journal-title":"J. Infect. Chemother."},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijantimicag.2018.07.004","article-title":"Evaluation of the efficacy and safety of ceftazidime\/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis","volume":"52","author":"Zhong","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2024.107275_bib114","article-title":"Polymyxins and their potential next generation as therapeutic antibiotics","volume":"10","author":"Vaara","year":"2019","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib115","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc13858","article-title":"High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria","volume":"18","author":"De Pascale","year":"2014","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C5MD00344J","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives","volume":"7","author":"Garneau-Tsodikova","year":"2016","journal-title":"Medchemcomm"},{"issue":"4","key":"10.1016\/j.micpath.2024.107275_bib117","doi-asserted-by":"crossref","first-page":"dlae127","DOI":"10.1093\/jacamr\/dlae127","article-title":"Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation","volume":"6","author":"Kherroubi","year":"2024","journal-title":"JAC-Antimicrob. Resist."},{"issue":"12","key":"10.1016\/j.micpath.2024.107275_bib118","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2174\/1570180816666190516113202","article-title":"Monobactams: a unique natural scaffold of four-membered ring skeleton, recent development to clinically overcome infections by multidrug-resistant microbes","volume":"16","author":"El-Shorbagi","year":"2019","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.micpath.2024.107275_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01986","article-title":"Phage display derived monoclonal antibodies: from bench to bedside","volume":"11","author":"Alfaleh","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2024.107275_bib120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/phar.1434","article-title":"Fosfomycin for the treatment of resistant gram-negative bacterial infections","volume":"34","author":"Reffert","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.micpath.2024.107275_bib121","article-title":"Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia","volume":"27","author":"Wozniak","year":"2022","journal-title":"Lancet. Reg. Health \u2013 West. Pac."},{"key":"10.1016\/j.micpath.2024.107275_bib122","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1017\/S0950268818003436","article-title":"Annual relative increased in inpatient mortality from antimicrobial resistant nosocomial infections in Thailand","volume":"147","author":"Phodha","year":"2019","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.micpath.2024.107275_bib123","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13756-019-0492-8","article-title":"Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia","volume":"8","author":"Chua","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"Suppl 4","key":"10.1016\/j.micpath.2024.107275_bib124","doi-asserted-by":"crossref","first-page":"iv57","DOI":"10.1136\/sextrans-2012-050910","article-title":"Moving forward in tackling antimicrobial resistance: WHO actions","volume":"89","author":"Lusti-Narasimhan","year":"2013","journal-title":"Sex. Transm. Infect."},{"issue":"11","key":"10.1016\/j.micpath.2024.107275_bib125","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for <em>Neisseria gonorrhoeae<\/em> 2017\u201318: a retrospective observational study","volume":"2","author":"Unemo","year":"2021","journal-title":"Lancet. Microbe."},{"key":"10.1016\/j.micpath.2024.107275_bib126","article-title":"Occurrence of OXA-48 carbapenemase and other \u03b2-lactamase genes in ESBL-producing multidrug resistant Escherichia coli from dogs and cats in the United States, 2009\u20132013","volume":"7","author":"Liu","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.107275_bib127","article-title":"The present and future of Whole genome sequencing (WGS) and Whole Metagenome sequencing (WMS) for surveillance of antimicrobial resistant microorganisms and antimicrobial resistance genes across the food chain","volume":"9","author":"Oniciuc","year":"2018","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.micpath.2024.107275_bib128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14787210.2021.1951705","article-title":"Antimicrobial resistance in low- and middle-income countries: current status and future directions","volume":"20","author":"Sulis","year":"2022","journal-title":"Expert Rev. Anti-infect. Ther."},{"issue":"3","key":"10.1016\/j.micpath.2024.107275_bib129","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00048-19","article-title":"Antimicrobial resistance surveillance in low- and middle-income countries: progress and challenges in eight South Asian and Southeast Asian countries","volume":"33","author":"Gandra","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2024.107275_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11020333","article-title":"The potential role of vaccines in preventing antimicrobial resistance (AMR): an update and future perspectives","volume":"11","author":"Costanzo","year":"2023","journal-title":"Vaccines"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024007423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024007423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T09:26:39Z","timestamp":1740389199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401024007423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":130,"alternative-id":["S0882401024007423"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107275","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging threats: Antimicrobial resistance in extended-spectrum beta-lactamase and carbapenem-resistant Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107275"}}